Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery
  2. Kiris, E.; Nuss, J. E.; Burnett, J. C.; Kota, K. P.; Koh, D. C.; Wanner, L. M.; Torres-Melendez, E.; Gussio, R.; Tessarollo, L.; Bavari, S.
  3. Stem Cell Research. 2011, May; 6(3): 195-205.
  1. 2.   Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication
  2. Li, B.; Peet, N. P.; Butler, M. M.; Burnett, J. C.; Moir, D. T.; Bowlin, T. L.
  3. Molecules. 2011, Jan; 16(1): 202-220.
  1. 3.   Pharmacophore Refinement Guides the Design of Nanomolar-Range Botulinum Neurotoxin Serotype A Light Chain Inhibitors
  2. Nuss, J. E.; Dong, Y. X.; Wanner, L. M.; Ruthel, G.; Wipf, P.; Gussio, R.; Vennerstrom, J. L.; Bavari, S.; Burnett, J. C.
  3. Acs Medicinal Chemistry Letters. 2010, Oct; 1(7): 301-305.
  1. 4.   Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
  2. Tsai, Y. C.; Maditz, R.; Kuo, C. L.; Fishman, P. S.; Shoemaker, C. B.; Oyler, G. A.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Sep; 107(38): 16554-16559.
  1. 5.   The alarmin functions of high-mobility group proteins
  2. Yang, D.; Tewary, P.; de la Rosa, G.; Wei, F.; Oppenheim, J. J.
  3. Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms. 2010, Jan-Feb; 1799(1-2): 157-163.
  1. 6.   Temporal characteristics of botulinum neurotoxin therapy
  2. Lebeda, F. J.; Cer, R. Z.; Stephens, R. M.; Mudunuri, U.
  3. Expert Review of Neurotherapeutics. 2010, Jan; 10(1): 93-103.
  1. 7.   Novel 4-aminoquinolines active against chloroquine-resistant and sensitive P. falciparum strains that also inhibit botulinum serotype A
  2. Solaja, B. A.; Opsenica, D.; Smith, K. S.; Milhous, W. K.; Terzic, N.; Opsenica, I.; Burnett, J. C.; Nuss, J.; Gussio, R.; Bavari, S.
  3. Journal of Medicinal Chemistry. 2008 51(15): 4388-4391.
  1. 8.   Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: Implications for therapeutic discovery
  2. Stahl, A. M.; Ruthel, G.; Torres-Melendez, E.; Kenny, T. A.; Panchal, R. G.; Bavari, S.
  3. Journal of Biomolecular Screening. 2007, Apr; 12(3): 370-377.
  1. 9.   Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons
  2. Burnett, J. C.; Ruthel, G.; Stegmann, C. M.; Panchal, R. G.; Nguyen, T. L.; Hermone, A. R.; Stafford, R. G.; Lane, D. J.; Kenny, T. A.; McGrath, C. F.; Wipf, P.; Stahl, A. M.; Schmidt, J. J.; Gussio, R.; Brunger, A. T.; Bavari, S.
  3. Journal of Biological Chemistry. 2007, Feb; 282(7): 5004-5014.
  1. 10.   Defensin participation in innate and adaptive immunity
  2. Yang, D.; Liu, Z. H.; Tewary, P.; Chen, Q.; De la Rosa, G.; Oppenheim, J. J.
  3. Current Pharmaceutical Design. 2007 13(30): 3131-3139.
  1. 11.   Alarmins initiate host Defense
  2. Oppenheim, J. J.; Tewary, P.; de la Rosa, G.; Yang, D.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 185-194.
  1. 12.   High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
  2. Yang, D.; Chen, Q.; Yang, H.; Tracey, K. J.; Bustin, M.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2007, Jan; 81(1): 59-66.
  1. 13.   Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice
  2. Lee, J. S.; Groebner, J. L.; Hadjipanayis, A. G.; Negley, D. L.; Schmaljohn, A. L.; Welkos, S. L.; Smith, L. A.; Smith, J. F.
  3. Vaccine. 2006, Nov; 24(47-48): 6886-6892.
  1. 14.   Ribonucleases in HIV type 1 inhibition: Effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression
  2. Bedoya, V. I.; Boasso, A.; Hardy, A. W.; Rybak, S.; Shearer, G. M.; Rugeles, M. T.
  3. Aids Research and Human Retroviruses. 2006, Sep; 22(9): 897-907.
  1. 15.   Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (H-C)) immune response and protection in the rhesus monkey
  2. Boles, J.; West, M.; Montgomery, V.; Tammariello, R.; Pitt, M. L. M.; Gibbs, P.; Smith, L.; LeClaire, R. D.
  3. Toxicon. 2006, Jun; 47(8): 877-884.
  1. 16.   Expression, purification, and characterization of Clostridium botulinum type B light chain
  2. Gilsdorf, J.; Gul, N.; Smith, L. A.
  3. Protein Expression and Purification. 2006, Apr; 46(2): 256-267.
  1. 17.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
  1. 18.   The evolving field of biodefence: Therapeutic developments and diagnostics
  2. Burnett, J. C.; Henchal, E. A.; Schmaljohn, A. L.; Bavari, S.
  3. Nature Reviews Drug Discovery. 2005 4(4): 281-297.
  1. 19.   Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation
  2. Yang, D.; Chen, Q.; Rosenberg, H. F.; Rybak, S. M.; Newton, D. L.; Wang, Z. Y.; Fu, Q.; Tchernev, V. T.; Wang, M. J.; Schweitzer, B.; Kingsmore, S. F.; Patel, D. D.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Journal of Immunology. 2004, NOV 15; 173(10): 6134-6142.
  1. 20.   Eosinophil-derived neurotoxin (EDN) is a selective chemoattractant and activator of dendritic cells
  2. Yang, D.; Chen, Q.; Kurosaka, K.; Howard, O. M. Z.; Rosenberg, H. F.; Rybak, S. M.; Kingsmore, S. F.; Oppenheim, J. J.
  3. Faseb Journal. 2004 18(5, Suppl. S): A1144-A1144.
  1. 21.   Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense
  2. Yang, D.; Biragyn, A.; Hoover, D. M.; Lubkowski, J.; Oppenheim, J. J.
  3. Annual Review of Immunology. 2004 22: 181-215.
  1. 22.   Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity
  2. Burnett, J. C.; Schmidt, J. J.; Stafford, R. G.; Panchal, R. G.; Nguyen, T. L.; Hermone, A. R.; Vennerstrom, J. L.; McGrath, C. F.; Lane, D. J.; Sausville, E. A.; Zaharevitz, D. W.; Gussio, R.; Bavari, S.
  3. Biochemical and Biophysical Research Communications. 2003 310(1): 84-93.
  1. 23.   Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition
  2. Rugeles, M. T.; Trubey, C. A.; Bedoya, V. I.; Pinto, L. A.; Oppenheim, J. J.; Rybak, S. A.; Shearer, G. M.
  3. Aids. 2003 17(4): 481-486.
  1. 24.   Enzymatic activity and inhibition of the neurotoxic complex vipoxin from the venom of Vipera ammodytes meridionalis
  2. Noetzel, C.; Chandra, V.; Perbandt, M.; Rajashankar, K.; Singh, T.; Aleksiev, B.; Kalkura, N.; Genov, N.; Betzel, C.
  3. Zeitschrift Fur Naturforschung C-a Journal of Biosciences. 2002 57(11-12): 1078-1083.
  1. 25.   Natural and engineered cytotoxic ribonucleases: Therapeutic potential
  2. Rybak, S. M.; Newton, D. L.
  3. Experimental Cell Research. 1999 253(2): 325-335.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel